CryoPen

CryoPen, Inc. was a medical device company specializing in the development and distribution of advanced cryosurgical tools for the treatment of benign skin lesions. Its flagship product, the CryoPen, is a handheld device that utilizes pressurized nitrous oxide to deliver extreme cold with pinpoint precision, allowing clinicians to treat lesions with millimeter accuracy. This technology significantly improved upon traditional liquid nitrogen methods by reducing patient discomfort, eliminating the need for specialized storage, and preventing damage to surrounding healthy tissue. The company's solutions were widely adopted across dermatology, podiatry, general practice, and veterinary medicine. In June 2019, CryoPen was acquired by CryoConcepts, LP, which integrated the technology into its broader portfolio of cryotherapy products.